Kyntra Bio, Inc. (KYNB) KPIs and segments
Close on Nov 17, 2026Market cap $8.26MP/E 0.0Yield –
KPIs & segments
Operating metrics and segments that drive Kyntra Bio's business
Kyntra Bio's revenue by segment, product and region, plus the counts and sizes it tags in its 10-K and 10-Q filings (XBRL). Each figure links to the filing it came from. A fuller KPI sheet built from earnings releases and presentations is on the way. See the segment tables for a trailing-twelve-month view, or how companies compare on operating metrics.
The chart is empty. Tick the box next to any metric in the table below to plot it — tick several to compare them on one chart.
| Add to chart | Metric | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Other Revenue - Contract Manufacturing($M) | 0.10 | 0.25 | 0.20 | 0.12 | 0.13 | 0.14 | 0.42 | 0.39 | 0.27 | 0.88 | 2.58 | 6.78 | |
Drug Product Revenue($M) | -1.58 | 3.49 | 1.08 | 0.96 | 1.22 | 2.60 | 2.72 | -0.26 | 0.73 | 24.5 | 1.05 | 1.32 | |
Earlier reporting (last reported 2024)2 | |||||||||||||
Italic numbers are calculated by StockData from reported figures (hover for the formula). Numbers with a dotted underline are read from the text of earnings releases and presentations; hover to see the exact sentence. Tick a row to add it to the chart above (up to 8 lines).
Methodology and excluded metrics
- Core rows come from the segment and revenue-disaggregation notes of 10-K and 10-Q filings (XBRL), linked to each filing. Fourth-quarter figures are the fiscal year less the first nine months (shown in italic).
Data updated 2026-08-13.
See a number that looks wrong?